Miransertib (ARQ 092) HCl
CAS: 1313883-00-9
Ref. 3D-NCC88300
| 10mg | 340.00 € | ||
| 25mg | 475.00 € | ||
| 50mg | 637.00 € | ||
| 100mg | 813.00 € | ||
| 250mg | 1,307.00 € |
Product Information
Miransertib is a potent, orally active small-molecule inhibitor of protein synthesis. It has been shown to inhibit the growth of cancer cells in vitro and in vivo, with activity against platinum-resistant ovarian cancer cells and prostate cancer cells. Miransertib also inhibits the production of the growth factor VEGF. In addition, miransertib has potent antitumor activity in diabetic patients and can be used to treat congestive heart failure. This drug is activated by sorafenib and has been shown to inhibit the production of human liver proteins as well as human endometrial proteins. Miransertib belongs to the sorafenib group of drugs.
Chemical properties
Technical inquiry about: 3D-NCC88300 Miransertib (ARQ 092) HCl
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
